Rule change in HK to usher in wave of US IPOs

August 01 2018

Changes allowing pre-revenue companies to list on the HKEx means that a number of biotech companies are likely to list on the exchange

Unlock this content.

The content you are trying to view is exclusive to our subscribers.

To unlock this content:

Take a Free Trial or Login

Topics

Equity News analysis Capital Markets IFLR Magazine July/August 2018 Hong Kong SAR United States China PRC

John Crabb

People and Markets Editor GlobalCapital